Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07275749 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acetyl-leucine in Post-stroke Ataxia

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 10, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Kafrelsheikh University
152 trials monitored
See 1 trial at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Along with the current clinical trial, the efficacy and safety of 4 gram of acetyl-leucine daily for three months in patients with post-stroke ataxia following posterior-circulation ischaemic stroke assessed through BBS, SARA, and mRS, and possible adverse effects.
Trial Details
NCT Number NCT07275749
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov